**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 614-16-4 |Benzoylacetonitrile | ca.100 | 210-369-1 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XI
Risk Phrases: 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. May be metabolized to cyanide which in turn
acts by inhibiting cytochrome oxidase impairing cellular
respiration.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. Metabolism may release cyanide, which may result in
headache, dizziness, weakness, collapse, unconsciousness and
possible death.
Inhalation:
Causes respiratory tract irritation. Can produce delayed pulmonary
edema. May be metabolized to cyanide which in turns act by inhibiting
cytochrome oxidase impairing cellular respiration.
Chronic:
Exposure to small amounts of cyanide compounds over long periods of
time is reported to cause loss of appetite, headache, weakness,
nausea, dizziness, and symptoms of irritation of the upper
respiratory tract and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up or absorb material, then place into a
suitable clean, dry, closed container for disposal. Avoid generating
dusty conditions. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Minimize dust generation and accumulation. Avoid
contact with eyes, skin, and clothing. Keep container tightly closed.
Avoid ingestion and inhalation. Use with adequate ventilation. Wash
clothing before reuse.
Storage:
Keep container closed when not in use. Store in a tightly closed
container. Store in a cool, dry, well-ventilated area away from
incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 614-16-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use. Wear a NIOSH/MSHA
or European Standard EN 149 approved full-facepiece
airline respirator in the positive pressure mode with
emergency escape provisions.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Powder
Color: light brown - brown
Odor: none reported
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 160 deg C @ 10.00mmHg
Freezing/Melting Point: 80.00 - 82.00 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: >135 deg C
Solubility in water: slightly soluble
Specific Gravity/Density:
Molecular Formula: C9H7NO
Molecular Weight: 145.16
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, irritating and
toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 614-16-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Benzoylacetonitrile -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
Other
No information available.
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XI
Risk Phrases:
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 37/39 Wear suitable gloves and eye/face
protection.
WGK (Water Danger/Protection)
CAS# 614-16-4: No information available.
Canada
CAS# 614-16-4 is listed on Canada's DSL List.
CAS# 614-16-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 614-16-4 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 8/24/1997 Revision #4 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Methacrylonitrile, 99% (stabilized with 50 ppm MEHQ)
| 126-98-7 |
|
Boron Trifluoride Dimethanol Complex (50-52 wt% BF3)
| 67-56-1 |
|
Dimethylsulfamoyl Chloride, 99% (GC)
| 13360-57-1 |
|
2,4-Dichloroanisole, 99+%
| 553-82-2 |
|
2-Fluorobenzaldehyde, 97%
| 446-52-6 |
|
Benzoylacetonitrile
| 614-16-4 |
|
3-Fluorobenzonitrile, 98%
| 403-54-3 |
|
3,3,5-Trimethylcyclohexanone, 97%
| 873-94-9 |
|
cis-4-Decenal, 98%
| 21662-09-9 |
|
Cyclohexyl bromide, 99%
| 108-85-0 |
|
Alpha, Alpha, Alpha,4-Tetrafluoro-O-Toluidine, 99%
| 393-39-5 |
|
4-Methoxy-3-Nitrobenzotrifluoride, 99%
| 394-25-2 |
|
Isatoic Anhydride, 98% (Titr.)
| 118-48-9 |
|
2,4'-Difluorobenzophenone, 98%
| 342-25-6 |
|
5-Chloro-2-(Methylamino)benzophenone, 99%
| 1022-13-5 |
|
Hydroquinone sulfonic acid, potassium salt tech.
| 21799-87-1 |
|
L-Leucyl-L-Alanine, Hydrate
| 7298-84-2 |
|
Trifluoroacetaldehyde ethyl hemiacetal, 90%
| 433-27-2 |
|
4-Sulfonic Calix[4]Arene Hydrate, 95%
| 0-01-1 |
|
(n-Propyl)triphenylphosphonium bromide, 99%
| 15912-75-1 |
|
5-Nitro-2-Furaldehyde Diacetate, 98%
| 92-55-7 |
|
3-Nitro-L-Tyrosine, 99%
| 621-44-3 |
|
2-(3-Methoxyphenyl)Cyclohexanone
| 15547-89-4 |
|
2,2'-Dihydroxy-4,4'-dimethoxybenzophenone, 98%
| 131-54-4 |
|
Hippuric Acid, 98%
| 495-69-2 |
|
Dibutyl oxalate, 99%
| 2050-60-4 |
|
N-(2-Hydroxyethyl)Morpholine, 99%
| 622-40-2 |
|
4-Methoxybenzamide (P-Anisamide), 97%
| 3424-93-9 |
|
Manganese(III) acetate dihydrate, 98%
| 993-02-2 |
|
Hexaketocyclohexane octahydrate, 97%
| 527-31-1 |
|
Prussian blue
| 14038-43-8 |
|
(S)-2-Amino-3-Methoxypropanoic Acid Hydrochloride, 98%
| 0-00-1 |
|
trans-1,2-Dichloroethylene, 99.7%, stabilized with 950 ppm BLO and
| 156-60-5 |
|
5-Bromovaleric acid, 97%
| 2067-33-6 |
|
gamma-Decalactone, 97%
| 706-14-9 |
|
Indophenol blue, 99% (uv-vis)
| 132-31-0 |
|
TETRAACETYLETHYLENEDIAMINE, 99.5+%
| 10543-57-4 |
|
Cis-2-Aminocyclohexanol Hydrochloride, 99+%
| 6936-47-6 |
|
5-Chloro-1-phenyl-1h-tetrazole, 97%
| 14210-25-4 |
|
3-Hydroxy-3-methyl-2-butanone, 92%
| 115-22-0 |
|
Precocene I, 99%
| 17598-02-6 |
|
1,3-Dichloroacetone, 99%
| 534-07-6 |
|
2,3-Pyrazinedicarboxamide, 97%
| 6164-78-9 |
|
4-Bromobenzoic Acid 97%
| 586-76-5 |
|
Molecular Sieves, 3A, 4 to 8 Mesh
| 0-00-1 |
|
M-(p-tert-butylphenoxy)benzaldehyde, 99%
| 69770-23-6 |
|
Lysergol
| 602-85-7 |
|
Poly(Vinyl Methyl Ketone) Average M.W. 500.000
| 25038-87-3 |
|
Adenine Sulfate, Dihydrate, 98% (Titr.)
| 321-30-2 |
|
2-(4-Aminophenyl)ethylamine, 95%
| 13472-00-9 |
|
|